Additionally, an increasing trend in the percentage of TH-positive cells was observed in the GBM organoids (4 weeks: 27.54% ± 4.36%, 12 weeks: 60.56% ± 2.68%).
← all excerpts
A tumorigenicity evaluation platform for cell therapies based on brain organoids.
1
—
—